1. Pink Sheet
  2. >>R&D
  3. >>Clinical Trials

Drug Development Tool Qualification: US FDA Offers Three-Step Review Process

 
• By Brenda Sandburg

FDA's proposed review timeline to qualify biomarkers, clinical outcome assessments, and animal models can actually be pretty quick – assuming submissions clear the initial "reviewability" hurdle. 

Big medical set including equipment , medical tools and drugs. Vector hand drawn medical collection - Vector

The US FDA has set up a three-step review process to qualify tools for use in drug development. But before beginning this procedure, the agency first determines the "reviewability" of a sponsor's submission.

FDA officials described how the agency is implementing the new qualification process for drug development tools, established by the 21st Century Cures Act, at a Dec. 11 public meeting

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D